Passage Bio, Inc.PASGNASDAQ

Revenue (LTM)

Net Income (LTM)

$-46M

+29.7% YoY

Free Cash Flow

$-32M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	-4	0	-1
Operating Income	-186	-138↑25.5%	-100↑27.6%	-70↑29.7%	-43↑38.7%
Net Income	-185	-136↑26.6%	-102↑25.0%	-65↑36.5%	-46↑29.7%
EBITDA	-176	-132↑25.2%	-98↑25.3%	-62↑36.9%	-42↑31.7%
EPS Diluted	-69.51	-50.00↑28.1%	-37.29↑25.4%	-21.44↑42.5%	-14.35↑33.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	129	35↓73.2%	22↓37.3%	38↑73.1%	46↑23.2%
Total Current Assets	325	197↓39.4%	118↓40.1%	79↓33.2%	48↓39.4%
Total Assets	355	244↓31.4%	151↓38.2%	102↓32.0%	62↓39.2%
Total Current Liabilities	29	18↓37.8%	16↓11.0%	19↑18.5%	23↑19.2%
Total Liabilities	36	42↑15.8%	39↓6.9%	41↑4.8%	44↑5.8%
Total Equity	319	201↓36.8%	111↓44.7%	61↓45.0%	19↓69.4%
Total Debt	0	27	26↓3.0%	25↓3.1%	24↓5.8%
Net Debt	-129	-7↑94.2%	5↑161.2%	-12↓363.8%	-22↓84.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-127	-118↑6.8%	-78↑33.8%	-48↑38.7%	-32↑34.3%
Capital Expenditure	-26	-5↑79.4%	-0↑97.2%	-0↑76.7%	0
Free Cash Flow	-153	-123↑19.0%	-78↑36.5%	-48↑38.8%	-32↑34.3%
Stock-Based Comp	33	19↓42.0%	11↓42.4%	6↓46.7%	3↓48.4%
Net Change in Cash	-6	-94↓1463.1%	-13↑86.3%	16↑223.1%	9↓45.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance